Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.25 USD | +0.23% | -1.23% | -8.82% |
05-13 | Baxter International's Clinolipid Injection Approved for Expanded Use in US | MT |
05-10 | TD Cowen Downgrades Baxter International to Hold From Buy, Price Target is $40 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.82% | 17.92B | |
-5.43% | 182B | |
+4.30% | 114B | |
-3.09% | 68.38B | |
+5.86% | 52.46B | |
+8.15% | 44.25B | |
+7.52% | 43.55B | |
+25.54% | 32.69B | |
+17.85% | 26.73B | |
+1.00% | 25.79B |
- Stock Market
- Equities
- BAX Stock
- News Baxter International Inc.
- UBS Adjusts Price Target on Baxter International to $40 From $42, Maintains Neutral Rating